Status:
COMPLETED
Low Dose Cyclophosphamide Treats Genital Warts
Lead Sponsor:
Huazhong University of Science and Technology
Conditions:
Genital Wart
Eligibility:
All Genders
18-60 years
Phase:
PHASE3
Brief Summary
Condylomata acuminata (CA) caused by human papillomavirus (HPV) is a common sexually transmitted disease with half a million new cases diagnosed in the United States per year. Recurrence is a major ch...
Detailed Description
Patients were first treated with CO2 laser therapy, and then treated with low-dose CY, orally 50 mg per day for 7 days.The CA recurrence were observed.
Eligibility Criteria
Inclusion
- Clinical diagnosis of large genital warts
Exclusion
- HPV type 6 or 11 was detected negatively by PCR method.
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2009
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT00999986
Start Date
January 1 2007
End Date
August 1 2009
Last Update
November 25 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tongji Hospital
Wuhan, Hubei, China, 430030